The vaccine, mycobacterium indicus pranii (MIP), which has been developed in India, is associated with prevention of which disease?

Answer: [C] Leprosy

Mycobacterium Indicus Pranii (MIP) is the world’s first vaccine developed in India for prevention of leprosy, and India will be the first to have a large-scale vaccination programme.  The vaccine has been developed by G P Talwar of National Institute of Immunology and has been approved by the Drug Controller General of India (DCGI) and the US-FDA. About 60% of the global leprosy patients live in India. The vaccine will help in eradicating the menace of Leprosy in India. The vaccine is now being used as a part of pilot programme in few districts of India, and if shows satisfactory results, the programme will be implemented in other high-prevalence districts across the country.

This question is a part of GKToday's Integrated IAS General Studies Module